Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 0.57.

  • Sanofi's Equity Ratio fell 354.22% to 0.57 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.57, marking a year-over-year decrease of 354.22%. This contributed to the annual value of 0.57 for FY2025, which is 354.22% down from last year.
  • Per Sanofi's latest filing, its Equity Ratio stood at 0.57 for Q4 2025, which was down 354.22% from 0.56 recorded in Q2 2025.
  • In the past 5 years, Sanofi's Equity Ratio registered a high of 0.59 during Q4 2022, and its lowest value of 0.02 during Q2 2021.
  • In the last 5 years, Sanofi's Equity Ratio had a median value of 0.58 in 2021 and averaged 0.52.
  • As far as peak fluctuations go, Sanofi's Equity Ratio plummeted by 9855.09% in 2021, and later surged by 250669.24% in 2022.
  • Over the past 5 years, Sanofi's Equity Ratio (Quarter) stood at 0.57 in 2021, then rose by 3.32% to 0.59 in 2022, then fell by 0.37% to 0.59 in 2023, then decreased by 0.28% to 0.59 in 2024, then fell by 3.54% to 0.57 in 2025.
  • Its Equity Ratio was 0.57 in Q4 2025, compared to 0.56 in Q2 2025 and 0.59 in Q4 2024.